Table 1.

Patients’ characteristics and outcomes

	On ICU admission						At the time of CEUS study							Outcomes
Patient number	Age, years	Main diagnosis	Chronic kidney disease	Diabetes	Hypertension	APACHE-III score	Mechanical ventilation	RIFLE	NA dosage (μg/minute)	Time on NA (hrs)	Other inotropes	ACE Inh < 48 h	Diuretics < 48 hrs	ICU LOS, days	RIFLE	RRT	Death
1	51	Septic shock	No	No	No	65	Yes	R	13	46	Milrinone	No	No	6	F	No	No
2	64	Septic shock	No	Yes	No	47	No	-	6	20	No	Yes	Yes	5	R	No	No
3	30	Septic shock	No	No	No	18	Yes	-	3.5	6	No	No	No	4	I	No	No
4	71	Septic shock	No	No	No	57	No	R	4	26	No	No	No	2	I	No	No
5	84	Septic shock	No	No	Yes	73	Yes	R	14	52	No	No	Yes	10	R	No	Yes
6	42	Status epilepticus	No	No	No	24	Yes	R	10	48	No	No	Yes	12	R	No	No
7	68	Septic shock	No	Yes	Yes	60	No	-	2	17	No	No	No	3	-	No	No
8	63	Septic shock	No	No	No	61	Yes	I	15	19	No	No	No	4	I	No	No
9	32	Septic shock	No	No	No	56	No	-	11	5	No	No	No	2	R	No	No
10	71	Septic shock	No	No	Yes	44	No	F	10	21	No	No	No	2	F	No	Yes
11	62	Septic shock	No	No	No	80	No	I	16	8	Vasopressin	No	No	7	I	No	No
12	65	Cardiogenic shock	No	No	No	75	Yes	-	8	16	No	No	Yes	4	-	No	No

APACHE, acute physiology and chronic health evaluation; NA, noradrenaline; RIFLE, risk, injury, failure, loss, end-stage kidney failure; ACE Inh, angiotensin converting enzyme inhibitors; LOS, length of stay; RRT, renal replacement therapy.